7 undervalued stock picks to beat the slump in September market

Although the tail end of the third quarter brought some unwanted volatility to the market, forward-thinking investors may want to use this time to strategize undervalued stock picks. One of the primary advantages of this approach is that such securities may not have much more to improve. This will appeal to risk-averse investors, who may be upset by the bullish corrections.

Another factor to consider when buying undervalued stocks is that the underlying businesses are overlooked. Even if they are associated with relevant industries, some companies do not attract the attention of Wall Street. However, smart market participants can use this dynamic to their advantage, positioning themselves ahead of the crowd.

Although investors don’t like to see their portfolios stained with crimson ink, the silver lining is that you don’t have to let the corrections lie. Below are undervalued stock picks to buy to help you get back on the right track.

MRK Merck $86.93
bhp BHP Group $50.97
valley valley $12.84
GM General Motors $39.96
C Citigroup $47.78
no objection certificate Northrop Grumman $486.17
In Micron Technology $52.35

Merck (MRK)

Merck (MRK) logo outside the corporate building

Source: atmosphere1/shutterstock.com

Arguably, a low-priced stock pick, one of the most compelling ideas among the pharmaceutical giant Merck (NYSE:MRK) now offers an interesting narrative that fears of the coronavirus pandemic are fading. On paper, MRK stock presents an attractive technical profile. On a year-over-year basis, shares are up 13%. For reference, benchmark S&P 500 The index is down about 19% during the same period.

statistically, GuruFocus Labels as MRK “Slightly underestimated.” Primarily, the company has a forward price-to-earnings (P/E) ratio of 11.7 times. This ratio is in line with the average forward P/E ratio of the pharmaceutical manufacturing industry, which is more than 14 times. In addition, Merck has strong profitability metrics. A highlight includes a net margin of 29%. In contrast, the industry median is only 3.85%.

Basically, Merck appeals to those seeking lower priced stocks as the pharmaceutical world can now focus on non-Covid-19 related solutions. For example, Merck’s cancer drug Keytruda should generate massively higher demand because the risk of covid infection, which previously protected many people, should generate greater demand. demand for medical services,

BHP Group (BHP)

Smartphone with the BHP Group logo in front of the BHP website.  BHP Stock.

Source: T. Schneider / Shutterstock

If you like a dash of cynicism in your low-priced stock selection, you may want to consider BHP Group (NYSE:bhp) An Australian multinational mining, metals and natural gas petroleum company, BHP brings a number of relevant resources to the table. These include copper, nickel and potash. The latter resource explains the reason for BHP’s inclusion in this list.

First, let’s get some key statistics out of the way. BHP stock represents a comparatively solid performance so far this year. Shares have slipped “only” 6%. Although nothing to write home about on an absolute basis, BHP outperforms the S&P 500.

apart from this, GuruFocus Believe in BHP “Slightly underestimated.” It currently has a P/E ratio of 4.4x, well below the industry average of 10.9x. Plus, the company has a price-to-free-cash-flow ratio of 5.2 times, lower than the industry average of 11.7 times.

However, it’s all about potash for me. Russia’s invasion of Ukraine, a huge source of global potash supply encountered a disturbance, That’s a net negative for the world, but a blatant positive for potash producers like BHP.

Ok)

Vale logo displayed on mobile phone with company webpage in background

Source: RafaPress/Shutterstock.com

One name that investors should arguably keep on their radar, whether or not they want to choose particularly undervalued stocks, is a Brazilian metals and mining firm. valley (NYSE:valley) More significantly, the company represents the world’s largest producer of iron ore and nickel. Again, with the last item, you probably see where I’m going.

Still, let’s discuss the “paper” reasons why analysts consider VALE to be one of the best stocks out there. According to GuruFocus, mining firm is “Slightly underestimated.” The forward P/E ratio of the company is 4.1 times. This is well below the metals and mining industry average forward P/E ratio of 9.6 times. At the same time, the company commands excellent long-term growth and profitability metrics. Its highlight is its net margin, which runs at 42.2%.

Now, let’s get to the basics. According to CNBCThe cathodes used in modern electric vehicle (EV) batteries are at least 60% nickel, As EVs become more integrated into mainstream society, the demand for nickel will increase. Thus, VALE being down 7.3% so far this year is probably a big discount.

General Motors (GM)

Image of General Motors logo on corporate building with clear sky in background.

Source: Katherine Wells/Shutterstock

Speaking of EVs, we have to talk General Motors (NYSE:GMAn American automotive icon, General Motors is doing a lot right. First, the company transitioned aggressively to electrification of mobility. So, it’s bringing back a lot of combustion classics like hammerBut in EV form.

The other factor to consider is that GM refuses to give up on traditional gearheads. With the strong debut of the eighth-generation Corvette, the automaker appeals to a number of demographic groups. Salute them, sincerely.

On paper, GM is down 35% this year, which doesn’t bring positive management to the table. Just for this reason, you can consider taking the shares as one of the undervalued stocks.

to be fair, GuruFocus Labels as GM “Quite valuable.” Nevertheless, I would like to state that the company has a forward P/E ratio of 6.4x. In contrast, the auto industry median is 9.2 times. After all, as GM is an iconic brand, consumers are likely to turn to its EVs instead of many other upstart products.

Citigroup (C)

The Citigroup (C) logo can be seen on the side of the company's office building.

Source: Willie Barton/Shutterstock

One of the largest financial institutions domestically and internationally, Citigroup (NYSE:C) presents an interesting profile for undervalued stock picks. With so many changes taking place in the global markets and the world economy, people need excellent guidance. Citigroup’s wealth management arm can provide just that.

In technical charts, C stock appears undervalued relative to the S&P 500. Since the start of the year, Citigroup shares have fallen 24%. To be clear, this is for a reason. With the economic crisis affecting a myriad of industries, the financial segment suffered implied commercial activity losses.

on paper, GuruFocus accepts Citigroup “Slightly underestimated.” The company has a P/E ratio of 6.1x, which is well below the industry average of 9.5x. In addition, Citi has a forward P/E ratio of 6.7 times, which is below the sector median of 8.4 times.

Basically, though, the opposite bullish case for Citigroup centers on deflation. One can also guide investors to make money during periods of inflation as the purchasing power of the dollar declines; Therefore, investors must do something with their funds.

However, deflation provides a guaranteed positive return by doing nothing at all. Thus, it is very difficult to provide profitable guidance as to where Citigroup experts should turn.

Northrop Grumman (NOC)

United States Air Force Northrop Grumman (NOC) RQ-4B Global Hawk unmanned surveillance aircraft.

Source: Viper-Zero/Shutterstock

One of the world’s largest defense contractors, Northrop Grumman (NYSE:no objection certificate) has clear implications with the war in Ukraine. When Russia decided to attack its neighbor, both US and European armies rushed to Ukraine’s aid.

Now, on paper, NOC does not appear to be an undervalued stock pick. Since the beginning of the year, Northrop shares have gained 25% of the market value. It is well above the major indices, which are in deep red colour. simultaneously, GuruFocus NOC labels as stock “Slightly overvalued.”

Still, it’s important to point out that the company runs a P/E ratio of 13.6 times, which is well below the sector mean of 28.3 times. Plus, Northrop has excellent long-term growth and profitability metrics.

However, the basics really do it for me. Along with Northrop provide support For Ukrainian resistance fighters, the enormous uncertainty in Russia could lead to economic problems. This could translate to massive power gaps in areas controlled or affected by the former Soviet Union. In other words, it is going to be a busy time for defense contractors.

Micron Technology (MU)

One Micron Technology, Inc.  An exterior image of the headquarters.  MU stock.

Source: Charles Knowles/Shutterstock

Undoubted, Micron Technology (NASDAQ:In) represents the highest risk consideration shown in this list of undeclared stocks. Still, it is hard to imagine that its semiconducting feature of data storage solutions will be deferred indefinitely. However, this has implications for the company’s market performance.

On a year-on-year basis, the stock of MU is witnessing a decline of 45%. For context, as awesome as it is, Nasdaq is down “only” 27% during the same period. However, for the extreme speculator, MU can be attractive. Again, the widespread demand for data storage only goes in one direction: up.

on paper, GuruFocus consider the micron “Very underrated.” It didn’t happen. The tech firm has a forward P/E ratio of 6.1 times. This is well below the industry average of 15 times. In addition, Micron rates highly compared to long-term comparisons for growth and profitability.

If you have some funds put aside for speculation, MU could be an interesting idea among undervalued stock picks.

On the date of publication, Josh Enomoto did not hold any position (either directly or indirectly) in the securities mentioned in this article. The opinions expressed in this article are those of the author, which is subject to InvestorPlace.com Publication Guidelines,

A former senior business analyst at Sony Electronics, Josh Enomoto has helped broker major contracts with Fortune Global 500 companies. Over the past several years, he has provided unique, important insights into the investment markets as well as various other industries including legal, construction management and healthcare.

Be the first to comment

Leave a Reply

Your email address will not be published.


*